Cite
HARVARD Citation
Li, B. et al. (2018). SMYD3 promoter hypomethylation is associated with the risk of colorectal cancer. Future oncology. pp. 1825-1834. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Li, B. et al. (2018). SMYD3 promoter hypomethylation is associated with the risk of colorectal cancer. Future oncology. pp. 1825-1834. [Online].